Baoxia Cui

15PUBLICATIONS
12CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 02, 2026
Splice-switching of the oncogenic BCS1L isoform suppresses ovarian cancer progression by disrupting mitochondrial function.

Meining Xu, Zixiang Wang, Siyuan Yang

|Oct 29, 2025
Causal Relationship Between Socioeconomic Inequality and Hormone-Related Gynecologic Diseases: A Two-Sample, Two-Step Mendelian Randomization Study.

Yi Yu, Zhonghao Mao, Lianlian Feng

|Sep 11, 2025
Proteomics-Based Mapping of the Lymph Node Metastasis Landscape in Cervical Cancer.

Yiping Hao, Qingqing Liu, Bingyu Wang

|Dec 02, 2024
Therapeutic Potential of IL-37 in Cervical Cancer: Suppression of Tumour Progression and Enhancement of CD47-Mediated Macrophage Phagocytosis.

Yuan Feng, Lianlian Feng, Bingyu Wang

|Aug 06, 2024
Targeting tumor-associated macrophage-derived CD74 improves efficacy of neoadjuvant chemotherapy in combination with PD-1 blockade for cervical cancer.

Zixiang Wang, Bingyu Wang, Yuan Feng

|Jan 10, 2024
Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.

Bingyu Wang, Zhonghao Mao, Jinwen Ye

Pageof 3

Frequent Collaborators

1 joint publications

Haiying Liu

1 joint publications

Xiaofang Zhang

1 joint publications

Yida Zhang

1 joint publications

Xingsheng Yang